nach oben

Graefe's Archive for Clinical and Experimental Ophthalmology

Erschienen in:

08.04.2017 | Letter to the Editor (by invitation)

Re: Switching therapy from bevacizumab to aflibercept for the management of persistent diabetic macular edema

verfasst von: Bobak Bahrami, Thomas Hong, Andrew Chang

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 7/2017

Einloggen, um Zugang zu erhalten

Excerpt

We acknowledge Drs. Călugăru for their interest in our recent publication “Switching therapy from bevacizumab to aflibercept for the management of persistent diabetic macular edema” (DME) [1]. …

Bahrami B, Hong T, Zhu M, Schlub TE, Chang A (2017) Switching therapy from bevacizumab to aflibercept for the management of persistent diabetic macular edema. Graefes Arch Clin Exp Ophthalmol. doi:10.1007/s00417-017-3624-y

Early Treatment Diabetic Retinopathy Study research group (1985) Photocoagulation for diabetic macular edema. Early treatment diabetic retinopathy study report number 1. Arch Ophthalmol 103:1796–1806CrossRef

Brown DM, Nguyen QD, Marcus DM et al (2013) Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE. Ophthalmology 120:2013–2022CrossRefPubMed

Wells JA, Glassman AR, Ayala AR et al (2016) Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema: two-year results from a comparative effectiveness randomized clinical trial. Ophthalmology 123:1351–1359CrossRefPubMedPubMedCentral

Korobelnik JF, Do DV, Schmidt-Erfurth U et al (2014) Intravitreal aflibercept for diabetic macular edema. Ophthalmology 121:2247–2254CrossRefPubMed

Ahmadieh H, Ramezani A, Shoeibi N et al (2008) Intravitreal bevacizumab with or without triamcinolone for refractory diabetic macular edema; a placebo-controlled, randomized clinical trial. Graefes Arch Clin Exp Ophthalmol. 246:483–489

Bahrami B, Zhu M, Hong T, Chang A (2016) Diabetic macular oedema: pathophysiology, management challenges and treatment resistance. Diabetologia 59:1594–1608CrossRefPubMed

Titel: Re: Switching therapy from bevacizumab to aflibercept for the management of persistent diabetic macular edema
verfasst von: Bobak Bahrami
Thomas Hong
Andrew Chang
Publikationsdatum: 08.04.2017
Verlag: Springer Berlin Heidelberg
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 7/2017
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI: https://doi.org/10.1007/s00417-017-3670-5

Neu im Fachgebiet Augenheilkunde

08.04.2024 | Therapieverfahren in der Augenheilkunde | CME

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Re: Switching therapy from bevacizumab to aflibercept for the management of persistent diabetic macular edema

Excerpt

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Bakterielle endogene Endophthalmitis

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Update Augenheilkunde

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2017

Analysis of autofluorescence pattern in birdshot chorioretinopathy

Electrophysiological assessment for early detection of retinal dysfunction in β-thalassemia major patients

Quantification of changes in foveal capillary architecture caused by idiopathic epiretinal membrane using OCT angiography

Antiplatelets and anticoagulants in vitreoretinal surgery, with a special emphasis on novel anticoagulants: a national survey and review

Pattern and causes of visual loss in Behçet’s uveitis: short-term and long-term outcomes

Fundamental principles of an anti-VEGF treatment regimen: optimal application of intravitreal anti–vascular endothelial growth factor therapy of macular diseases

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Bakterielle endogene Endophthalmitis

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Update Augenheilkunde